Get started
Author

Mélodie Tazdait

Observed names: M. Tazdait, M. Tazdaït, Melodie Tazdait, Mélodie Tazdaït
OpenAlex ID: A5013065802
Patterns of responses in metastatic NSCLC during PD-1 or PDL-1 inhibitor therapy: Comparison of RECIST 1.1, irRECIST and iRECIST criteria
2017 · M. Tazdait, L. Mezquita, et al. · European Journal of Cancer · 349
Hepatic arterial infusion of oxaliplatin plus systemic chemotherapy and targeted therapy for unresectable colorectal liver metastases
2020 · Alice Boilève, Astrid De Cuyper, et al. · European Journal of Cancer · 26
Association of metastatic pattern and molecular status in stage IV non-small cell lung cancer adenocarcinoma
2020 · Alison Dormieux, Laura Mezquita, et al. · European Radiology · 24
The natural history of fibroblast growth factor receptor (FGFR)-altered cholangiocarcinoma (CCA).
2020 · Lipika Goyal, Angela Lamarca, et al. · Journal of Clinical Oncology · 11
Clinical and molecular features of patients with cholangiocarcinoma harboring FGFR genetic alterations.
2019 · Alice Boileve, Islam Baiev, et al. · Journal of Clinical Oncology · 6
Interventional Radiology for Colorectal Liver Metastases
2020 · Frederic Deschamps, Maxime Ronot, et al. · Current Colorectal Cancer Reports · 4
Patterns of progression under antiPD1/PDL1 in advanced NSCLC patients allow discriminating pseudo-progression from real progression
2017 · C. Caramella, M. Tazdait, et al. · Annals of Oncology · 4
Bilateral adrenal haematoma complicated by adrenal insufficiency in a patient treated with bevacizumab
2021 · Cristina Smolenschi, Melodie Tazdait, et al. · BMJ Case Reports · 3
Prediction of the molecular status in non-small cell lung cancer based on metastatic pattern: A free webtool powered by artificial intelligence.
2020 · Benjamin Besse, Alison Dormieux, et al. · Journal of Clinical Oncology
Évaluation radiologique dans le cancer bronchique non à petites cellules métastatique sous anti-PD1 et anti-PD-L1 : comparaison des critères RECIST 1.1, irRECIST et iRECIST
2017 · Mélodie Tazdaït · HAL (Le Centre pour la Communication Scientifique Directe)
Patterns of progression under antiPD1/PDL1 in advanced NSCLC patients allow discriminating pseudo-progression from real progression
2017 · C. Caramella, M. Tazdait, et al. · Annals of Oncology
Radiothérapie interne par dichlorure de radium223 : résultats préliminaires
2015 · M. Basely, D. Métivier, et al. · Médecine Nucléaire
Works count: 12
Citation count: 427
H-index: 5
I10-index: 4
Year
Topic
Type